Internal Medicine, Pulmonary Disease · Fountain Valley, CA
NPI
1689786139
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
11100 Warner Ave Ste 120
Fountain Valley, CA, 92708
Phone (714) 672-0049
Groups this clinician bills Medicare through
Medicare paid, 2024
$496K
5,048 services
Medicare patients, 2024
825
Average age 76
Drug cost, 2024
$5.1M
7,742 prescriptions
Company payments, 2025
$6,087
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samarjit Singh was code 99233 (hospital e&m - subsequent), 1,454 times for 361 patients. In total Samarjit Singh billed 5,048 services in 36 codes, and Medicare paid $496K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,454 | 361 | $97.27 | $141K |
| 99214 Office E&M - Established | Office | 1,101 | 386 | $104.42 | $115K |
| 99291 Critical Care E&M | Facility | 821 | 217 | $172.74 | $142K |
| 96372 Injection Administration | Office | 197 | 50 | $12.24 | $2,411 |
| 99223 Hospital E&M - Initial | Facility | 173 | 149 | $142.22 | $25K |
| 99205 Office E&M - New | Office | 130 | 130 | $184.78 | $24K |
| 94618 Pulmonary Function Testing | Office | 110 | 108 | $29.39 | $3,233 |
| 94640 Treatment - Miscellaneous | Office | 108 | 106 | $7.33 | $791 |
| 94060 Pulmonary Function Testing | Office | 106 | 105 | $34.87 | $3,696 |
| 94729 Pulmonary Function Testing | Office | 106 | 105 | $51.78 | $5,489 |
| 94200 Pulmonary Function Testing | Office | 106 | 105 | $13.51 | $1,433 |
| 94726 Pulmonary Function Testing | Office | 106 | 105 | $50.66 | $5,370 |
| J0517 Injection, benralizumab, 1 mg | Office | 104 | 35 | $0.01 | $1 |
| 99215 Office E&M - Established | Office | 86 | 80 | $147.31 | $13K |
| 99292 Critical Care E&M | Facility | 79 | 56 | $86.31 | $6,818 |
By year: 2022 $546K for 5,057 services; 2023 $572K for 5,522 services; 2024 $496K for 5,048 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samarjit Singh prescribed most often to Medicare patients was Azelastine Hcl, with 1,010 prescriptions and refills. In total Samarjit Singh wrote 7,742 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 1,010 | 2,275 | 442 | $34K |
| Montelukast Sodium Generic | 944 | 2,626 | 352 | $11K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 854 | 1,020 | 210 | $633K |
| Prednisone Generic | 661 | 697 | 362 | $1,915 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 448 | 479 | 177 | $9,974 |
| Breo Ellipta Fluticasone/Vilanterol | 405 | 521 | 92 | $199K |
| Doxycycline Hyclate Generic | 306 | 306 | 228 | $1,595 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 237 | 299 | 44 | $132K |
| Pantoprazole Sodium Generic | 229 | 551 | 96 | $2,116 |
| Ipratropium Bromide Generic | 210 | 435 | 94 | $11K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 208 | 244 | 54 | $149K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 178 | 238 | 54 | $16K |
| Fasenra Benralizumab | 135 | 242 | 34 | $720K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 130 | 162 | 29 | $18K |
| Spiriva Respimat Tiotropium Bromide | 128 | 156 | 32 | $79K |
Brand drugs: 3,016 claims; generic drugs: 4,726 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samarjit Singh $6,087 ($6,087 in general payments such as food, travel and fees) from 33 companies. The largest payer was Becton, Dickinson and Company with $1,100.
| Company | Payments | Amount |
|---|---|---|
| Becton, Dickinson and Company BDX | 1 | $1,100 |
| AstraZeneca Pharmaceuticals LP AZN | 32 | $865 |
| GlaxoSmithKline, LLC. GSK | 51 | $863 |
| Genzyme Corporation SNY | 11 | $292 |
| Verona Pharma, Inc. VRNA | 12 | $287 |
| Amgen Inc. AMGN | 13 | $265 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $250 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $243 |
| Viatris Specialty LLC | 12 | $233 |
| Merck Sharp & Dohme LLC MRK | 6 | $170 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.